Search

Your search keyword '"Pehlivan, Y."' showing total 373 results

Search Constraints

Start Over You searched for: Author "Pehlivan, Y." Remove constraint Author: "Pehlivan, Y."
373 results on '"Pehlivan, Y."'

Search Results

1. Spin-Flavor Precession Phase Effects in Supernova

2. Time dependent signatures of core-collapse supernova neutrinos at HALO

3. Neutrino Spectral Split in the Exact Many Body Formalism

5. Possible effects of collective neutrino oscillations in the three flavor multi-angle simulations on supernova $\nu p$ process

6. POS0933 THE FREQUENCY OF AORTIC AND MITRAL VALVE INVOLVEMENT IN PATIENTS WITH TAKAYASU ARTERITIS

7. AB1328 IS THERE A NEED FOR ROUTINE IMAGING FOLLOW-UP IN PATIENTS WITH TAKAYASU ARTERITIS?

8. Astrophysical Neutrinos and Flavor Evolution With Self Interaction

9. Spectral splits of neutrinos as a BCS-BEC crossover type phenomenon

10. Neutrino Magnetic Moment, CP Violation and Flavor Oscillations in Matter

11. Exact Methods for Self Interacting Neutrinos

12. A Big-Bang Nucleosynthesis Limit on the Neutral Fermion Decays into Neutrinos

13. Solution to Big-Bang Nucleosynthesis in Hybrid Axion Dark Matter Model

14. Spin-flavor precession phase effects in supernova

15. Invariants of Collective Neutrino Oscillations

16. Symmetry and Supersymmetry in Nuclear Pairing: Exact Solutions

17. The retrospective evaluation of efficacy and safety data after switching from originator rituximab to biosimilar rituximab (CT-P10) in patients diagnosed with systemic lupus erythematosus: a single-center experience.

18. An Exactly Solvable Supersymmetric Model of Semimagic Nuclei

19. Quantum Invariants of the Pairing Hamiltonian

20. Solutions of Nuclear Pairing

21. Supersymmetry and Nuclear Pairing

22. Spectra and Symmetry in Nuclear Pairing

23. Neutrino-Neutrino Interactions and Flavor Mixing in Dense Matter

24. Solutions of the Gaudin Equation and Gaudin Algebras

25. Exactly Solvable Pairing Model Using an Extension of Richardson-Gaudin Approach

26. An Exactly Solvable Model of Interacting Bosons

27. Pan-immune-inflammation value could be a new marker to differentiate between vascular Behçet's disease and non-vascular Behçet's disease.

28. POS0879 THE IMPACT OF 6-MONTH DELAY IN DIAGNOSIS ON CLINICAL AND FUNCTIONAL STATUS IN THE PSA PATIENTS UNDER BDMARD TREATMENT: RESULTS FROM TREASURE DATABASE

29. POS0923 THE TRANSITION FROM ACTIVE LESIONS TO STRUCTURAL CHANGES ON SACROILIAC MRI AND ITS ASSOCIATED FACTORS

30. AB1014 RADIOGRAPHIC VERSUS NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: RESULTS FROM TREASURE DATABASE

31. Comparison of clinicodemographic characteristics and pattern of vascular involvement in 126 patients with Takayasu arteritis: a report from Iran and Turkey

32. Risk factors for malignancy in systemic sclerosis patients

33. COVID-19 VACCINATION OF SPONDYLOARTHRITIS PATIENTS RECEIVING BIOLOGICAL THERAPY: REAL-LIFE DATA

34. AB1088 COVID-19 VACCINATION OF SPONDYLOARTHRITIS PATIENTS RECEIVING BIOLOGICAL THERAPY: REAL-LIFE DATA

35. AB0420 UNINTENTIONAL MONOTHERAPY IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING TOFACITINIB AND DRUG SURVIVAL RATE OF TOFACITINIB

36. POS1184 EPIDEMIOLOGICAL CHARACTERISTICS OF VIRAL HEPATITIS IN PATIENTS WITH RHEUMATIC DISEASES – IMPLICATIONS FROM TREASURE DATABASE

37. AB0355 THE DIFFERENCES BETWEEN THE FIRST PREFERRED BIOLOGICAL DMARD AND THE DRUG SURVIVAL IN GERIATRIC AND YOUNGER ADULT POPULATION WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS: TREASURE REAL-LIFE DATA

38. AB0762 Incidence Of Anterior Uveitis In Axial Spondyloarthritis During Secukinumab Treatment: TWO YEARS REAL LIFE EXPERIENCE FROM TURKBIO REGISTRY

39. AB0774 Paradoxical reactions, especially psoriasis in rheumatology patients receiving biologic therapy from the Treasure database: a 5-year follow-up study

40. AB0766 Biologic Drug Preferences of Turkish Rheumatologists in Spondiloartropathy Patients with Advanced Chronic Renal Disease

41. POS1008 FACTORS ASSOCIATED WITH HIP INVOLVEMENT AND ITS IMPACT ON TREATMENT DECISION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS; TREASURE EXPERIENCE

42. Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries

44. AB0479 LONGTERM RETENTION RATE OF CERTOLIZUMAB PEGOL IN AXIAL SPONDYLOARTHRITIS IS HIGHER: DATA FROM TURKBIO

45. AB0561 DISEASE DURATION AND HLA-B27 POSITIVITY ALTER LONGTERM RETENTION RATE OF CERTOLIZUMAB PEGOL IN PATIENTS WITH PSORIATIC ARTHRITIS

46. POS0935 DO PERIPHERAL AND EXTRA MUSCULOSKELETAL MANIFESTATIONS HAVE AN IMPACT ON BIOLOGIC DMARD PRESCRIBING PATTERNS IN AXIAL SPONDYLOARTHRITIS: THE RESULTS OF TREASURE EXPERIENCE

47. AB0229 A NATIONAL, MULTICENTER, SECONDARY DATA USE STUDY EVALUATING EFFICACY AND RETENTION OF FIRST-LINE BIOLOGIC TREATMENT WITH TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN REAL-LIFE SETTING FROM TURKBIO REGISTRY

Catalog

Books, media, physical & digital resources